HistoIndex® is a MedTech company that specializes in its proprietary integrated stain-free AI digital pathology platform, as well as in the provision of related services, to assist pathologists in diagnosing various diseases. HistoIndex was co-founded by Dr. Gideon Ho, CEO, and Dr. Dean Tai, CSO.
Website
Website
Employees: 11-50
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | SEEDS Capi... | seedscapit... |
Mentions in press and media 19
| Date | Title | Description |
| 21.01.2026 | HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services | SINGAPORE, Jan. 21, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Institute (HRI). HRI is a leading research instit... |
| 11.08.2025 | HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment | SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the Uni... |
| 05.05.2025 | HistoIndex Raises SGD9M in Funding | HistoIndex, a Singapore-based company developing imaging solutions for biological tissues, raised SGD9M in funding. The round was led by OCBC with participation from ZIG Ventures and SEEDS Capital. The company intends to use the funds to ex... |
| 03.05.2025 | HistoIndex: Pioneering the Future of Liver Disease Diagnostics | In the bustling landscape of medical technology, HistoIndex stands out like a lighthouse guiding ships through fog. This Singapore-based company is not just another player in the healthcare field; it’s a trailblazer. With its innovative bio... |
| 02.05.2025 | HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion | SINGAPORE, May 2, 2025 /PRNewswire/ -- HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic... |
| 09.12.2024 | BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL | SINGAPORE, Dec. 9, 2024 /PRNewswire/ -- A newly published collaborative study[1] in the Journal of Hepatology, featuring HistoIndex – a global leader in stain-free digital pathology solutions for managing fibrotic diseases – alongside Merck... |
| 09.11.2024 | HistoIndex to Present Latest Findings on AI-based Analysis using Stain-free Digital Pathology with 12 Accepted Abstracts at AASLD The Liver Meeting® 2024 | SINGAPORE, Nov. 9, 2024 /PRNewswire/ -- HistoIndex, a pioneering leader in artificial intelligence (AI) and stain-free digital pathology, will present its latest research findings and advancements in AI-based analysis at the 75th The Liver ... |
| 01.07.2024 | HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board | Company to appoint Prof. Arun J. Sanyal as the new Chairman of HistoIndex's Scientific Advisory Board, bringing unparalleled expertise to guide future innovations. Prof. Vlad Ratziu joins the Scientific Advisory Board to strengthen the Comp... |
| 01.07.2024 | HistoIndex Charts New Course in Liver Disease Innovation: Announces Pivotal Changes to Scientific Advisory Board | Company to appoint Prof. Arun J. Sanyal as the new Chairman of HistoIndex's Scientific Advisory Board, bringing unparalleled expertise to guide future innovations. Prof. Vlad Ratziu joins the Scientific Advisory Board to strengthen the Comp... |
| 03.06.2024 | HistoIndex to Showcase Groundbreaking AI-powered Stain-free Digital Pathology Advances with 8 Accepted Abstracts at EASL Congress 2024 | Company to deliver two oral and six poster presentations, including one TOP poster and one selected for poster tour, further reinforcing its leadership position in MASH digital pathology. HistoIndex's AI-driven solutions provide unprecedent... |
Show more